Here we demonstrated that FASn and CD36 are the direct target genes of AP1, and Hcy activates it to induce their expressions, concurrently stimulating de novo FFA synthesis and uptake to promote hepatic lipid deposition and steatosis. The gene discussed is FASN; the disease is steatosis.